Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of ATP2A1 mRNA | affects expression | 17562736
|
C014949 |
acetylhydrazine |
acetylhydrazine results in decreased expression of ATP2A1 mRNA | decreases expression | 15282401
|
D001241 |
Aspirin |
Aspirin results in increased expression of ATP2A1 mRNA | increases expression | 11906190
|
D002084 |
Butylated Hydroxytoluene |
Butylated Hydroxytoluene inhibits the reaction [[ferrous sulfate co-treated with Edetic Acid] results in decreased activity of ATP2A1 protein] | affects cotreatment|decreases activity|decreases reaction | 12870653
|
D002084 |
Butylated Hydroxytoluene |
Butylated Hydroxytoluene inhibits the reaction [Free Radicals results in decreased activity of ATP2A1 protein] | decreases activity|decreases reaction | 12870653
|
D002118 |
Calcium |
Calcium binds to and affects the folding of ATP2A1 protein | affects binding|affects folding | 16618114
|
D002118 |
Calcium |
ATP2A1 protein affects the transport of Calcium | affects transport | 11230109
|
C100106 |
dicarbine |
dicarbine inhibits the reaction [[ferrous sulfate co-treated with Edetic Acid] results in decreased activity of ATP2A1 protein] | affects cotreatment|decreases activity|decreases reaction | 12870653
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in decreased expression of ATP2A1 mRNA | decreases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of ATP2A1 mRNA] | decreases expression|decreases reaction | 17942915
|
D004317 |
Doxorubicin |
Doxorubicin affects the activity of ATP2A1 protein | affects activity | 15937726
|
D004317 |
Doxorubicin |
Tamoxifen inhibits the reaction [Doxorubicin affects the activity of ATP2A1 protein] | affects activity|decreases reaction | 15937726
|
D004492 |
Edetic Acid |
Butylated Hydroxytoluene inhibits the reaction [[ferrous sulfate co-treated with Edetic Acid] results in decreased activity of ATP2A1 protein] | affects cotreatment|decreases activity|decreases reaction | 12870653
|
D004492 |
Edetic Acid |
dicarbine inhibits the reaction [[ferrous sulfate co-treated with Edetic Acid] results in decreased activity of ATP2A1 protein] | affects cotreatment|decreases activity|decreases reaction | 12870653
|
D004492 |
Edetic Acid |
[ferrous sulfate co-treated with Edetic Acid] results in decreased activity of ATP2A1 protein | affects cotreatment|decreases activity | 12870653
|
C020748 |
ferrous sulfate |
Butylated Hydroxytoluene inhibits the reaction [[ferrous sulfate co-treated with Edetic Acid] results in decreased activity of ATP2A1 protein] | affects cotreatment|decreases activity|decreases reaction | 12870653
|
C020748 |
ferrous sulfate |
dicarbine inhibits the reaction [[ferrous sulfate co-treated with Edetic Acid] results in decreased activity of ATP2A1 protein] | affects cotreatment|decreases activity|decreases reaction | 12870653
|
C020748 |
ferrous sulfate |
[ferrous sulfate co-treated with Edetic Acid] results in decreased activity of ATP2A1 protein | affects cotreatment|decreases activity | 12870653
|
D005609 |
Free Radicals |
Butylated Hydroxytoluene inhibits the reaction [Free Radicals results in decreased activity of ATP2A1 protein] | decreases activity|decreases reaction | 12870653
|
D005609 |
Free Radicals |
Free Radicals results in decreased activity of ATP2A1 protein | decreases activity | 12870653
|
C029424 |
hydrazine |
hydrazine results in decreased expression of ATP2A1 mRNA | decreases expression | 15282401
|
D008274 |
Magnesium |
Magnesium binds to and affects the folding of ATP2A1 protein | affects binding|affects folding | 16618114
|
D008713 |
Methimazole |
Methimazole results in decreased expression of ATP2A1 mRNA | decreases expression | 17403546
|
C494474 |
perchlorate |
perchlorate results in decreased expression of ATP2A1 mRNA | decreases expression | 17403546
|
D010710 |
Phosphates |
Phosphates binds to and affects the folding of ATP2A1 protein | affects binding|affects folding | 16618114
|
D011441 |
Propylthiouracil |
Propylthiouracil results in decreased expression of ATP2A1 mRNA | decreases expression | 17403546
|
D013467 |
Sulindac |
Sulindac results in decreased expression of ATP2A1 mRNA | decreases expression | 11906190
|
D013629 |
Tamoxifen |
Tamoxifen inhibits the reaction [Doxorubicin affects the activity of ATP2A1 protein] | affects activity|decreases reaction | 15937726
|
C020806 |
tetrabromobisphenol A |
tetrabromobisphenol A results in decreased activity of ATP2A1 protein | decreases activity | 18329244
|
C020806 |
tetrabromobisphenol A |
tetrabromobisphenol A results in decreased activity of ATP2A1 protein | decreases activity | 17784851
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ATP2A1 mRNA | increases expression | 15716485
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of ATP2A1 mRNA | decreases expression | 18230668
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Sulindac |
12.59 | 14745880 |
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
12.59 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.72 | 15322242 14514962 11752688 |
MESH:D058186 |
Acute Kidney Injury |
|
Sulindac |
4.19 | 7897758 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.76 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Sulindac |
4.76 | 11910360 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
11.09 | 10737359 6695378 |
MESH:D000236 |
Adenoma |
|
Magnesium |
11.09 | 17823441 |
MESH:D000236 |
Adenoma |
|
Sulindac |
11.09 | 10223192 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
9.62 | 19052882 16434500 17162532 19061943 18056438 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.62 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Sulindac |
4.48 | 19003578 17611924 11535846 15623613 12394442 11874996 16460482 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.42 | 21441931 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.51 | 15955085 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.83 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.71 | 10982225 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.00 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.23 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.31 | 16456186 |
MESH:D055963 |
Asthma, Aspirin-Induced |
|
Aspirin |
4.59 | 20485159 12372130 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.43 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Magnesium |
2.43 | 16846101 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.27 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
ferrous sulfate |
21.09 | 6421970 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Propylthiouracil |
21.09 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
21.09 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
21.09 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.66 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.68 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.57 | 14601052 |
MESH:D001913 |
Bowen's Disease |
|
Sulindac |
5.22 | 11207687 |
MESH:D001932 |
Brain Neoplasms |
|
Aspirin |
8.75 | 15481559 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
8.75 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Aspirin |
3.69 | 15161893 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
3.69 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
3.69 | 19526202 17426702 15939500 16935488 15136595 15567936 16826403 16595493 15993339 16264153 16096432 18382427 16115903 15994142 18628466 16322301 18234424 15634643 15692762 18695136 15668708 17983394 17369602 11325840 |
MESH:D001943 |
Breast Neoplasms |
|
Sulindac |
3.69 | 16642371 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
3.69 | 15565566 16273361 19011961 19142967 20390343 20135344 20544844 19059307 19155303 16202921 19084267 19103187 19288272 18351453 17893378 18855134 17261762 18997820 19200415 18821012 19221464 20005174 18629630 20065188 19189210 19066611 11161223 19487384 21152245 17049068 20859285 17242785 19189212 17440819 18815881 19244106 15668708 16818667 19115204 18425577 16873071 19410462 19289846 21138602 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
3.69 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
3.69 | 16166294 16443354 16873071 |
MESH:C536607 |
Brody myopathy |
marker/mechanism |
|
| |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.46 | 16813970 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.68 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.69 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.38 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.03 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
8.64 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
8.64 | 19208518 19171122 16569478 17761372 20432363 17055752 16328049 17978847 17162532 19539802 21159647 10672840 16935385 20514400 19383236 17173139 16779866 16288022 16830150 18788625 19418558 19919837 16540662 16878318 10737359 18506893 20214788 17138121 16502159 19701751 19107877 3581430 20727157 19519916 20512989 20007298 18971187 19052882 18494052 3084413 11831363 17428255 18056438 18785209 19822196 20524982 20101231 18393292 18665156 18210153 16681979 20935162 16698587 19394651 18691550 20084675 18978308 16807293 19335982 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
8.64 | 16234567 18059187 16023760 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
8.64 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
8.64 | 1917145 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.10 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
4.65 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.65 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.50 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.30 | 18850075 16120746 18670907 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.44 | 16651473 16612575 15811867 17519947 17131338 15476868 18627295 17308081 17928571 17007740 16731534 16455267 16952015 16242529 16109756 17924179 16278810 17382496 16364871 17974986 17351982 17329180 15505089 16269455 15792986 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.90 | 16243910 17334414 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
6.97 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
6.97 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
2.77 | 21159647 17174075 2727394 7505956 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.46 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.95 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.95 | 16835633 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.03 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.58 | 15340226 8697196 15668235 12621046 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.58 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.57 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Aspirin |
4.28 | 12411196 |
MESH:D003110 |
Colonic Neoplasms |
|
Sulindac |
4.28 | 12902858 12458338 |
MESH:D003111 |
Colonic Polyps |
|
Magnesium |
5.93 | 17823441 |
MESH:D015179 |
Colorectal Neoplasms |
|
Aspirin |
4.85 | 17047198 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
4.85 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Magnesium |
4.85 | 17823441 |
MESH:D015179 |
Colorectal Neoplasms |
|
Sulindac |
4.85 | 11197048 11076880 10666051 18059344 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.95 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.41 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.41 | 16925845 9125849 9211117 10589399 9142499 8800419 9224671 9664655 14991402 17551590 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.23 | 19031437 |
MESH:D002658 |
Developmental Disabilities |
|
Magnesium |
4.82 | 16846101 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.11 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.11 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.36 | 19279558 |
MESH:D003930 |
Diabetic Retinopathy |
|
Sulindac |
5.05 | 17621415 12861449 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
8.64 | 16227642 16109766 12153990 19085960 11529661 16485898 19739265 12958197 10663392 2444490 12540782 19923254 11461765 19370779 19416960 11421492 12705907 17562736 16781746 16177239 14550746 16393943 14725611 15968718 11834606 16081117 18071297 17522070 17906064 12392966 14986274 12594235 10915739 19164858 11287661 18713872 11739529 11743745 19420014 15619225 10774834 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
8.64 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
8.64 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.64 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.97 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.79 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.79 | 11462148 |
MESH:D004487 |
Edema |
|
Aspirin |
6.66 | 17259670 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.66 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.51 | 16714409 15322242 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.51 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
3.41 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
12.00 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
12.00 | 20544844 16202921 17893378 19155303 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
12.00 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Sulindac |
8.80 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.80 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.03 | 18037988 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.99 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
Sulindac |
3.10 | 12235107 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.51 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.51 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
7.43 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
7.43 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.16 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.33 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Sulindac |
12.52 | 14745880 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
12.52 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
18.79 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Sulindac |
18.79 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
18.79 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.19 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
8.19 | 17994277 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.55 | 16983495 |
MESH:D005764 |
Gastroesophageal Reflux |
|
Sulindac |
4.88 | 11910360 |
MESH:D005909 |
Glioblastoma |
|
Aspirin |
11.53 | 12870263 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
11.53 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
11.53 | 17312396 |
MESH:D006042 |
Goiter |
|
perchlorate |
5.18 | 18801409 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.47 | 10696789 |
MESH:D006261 |
Headache |
|
Aspirin |
4.83 | 15240983 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
7.55 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.55 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.03 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.31 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.31 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.39 | 14766674 16144979 16495754 16244371 16879835 16330681 17875725 18674790 16244372 17888722 18006777 12587719 16707910 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.26 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.78 | 15692506 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.21 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.76 | 12621046 15340226 16120746 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.30 | 17606976 15147373 18501091 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.92 | 8697196 15340226 16959395 18606429 16354765 |
MESH:D012001 |
Hyperacusis |
|
Aspirin |
5.63 | 15240983 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.28 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.28 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.44 | 16778211 |
MESH:D006967 |
Hypersensitivity |
|
Butylated Hydroxytoluene |
4.39 | 17604070 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.86 | 18670907 18850075 |
MESH:D006980 |
Hyperthyroidism |
|
Methimazole |
5.49 | 14678291 |
MESH:D007037 |
Hypothyroidism |
|
Methimazole |
11.52 | 18031379 |
MESH:D007037 |
Hypothyroidism |
|
Propylthiouracil |
11.52 | 18031379 8137927 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
11.43 | 18785209 |
MESH:D007249 |
Inflammation |
|
Sulindac |
11.43 | 3291741 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
11.43 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
11.43 | 12200463 12878042 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.64 | 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
|
Sulindac |
4.52 | 12351151 10213222 12584176 10223192 12663524 12628509 |
MESH:D007417 |
Intestinal Polyps |
|
Sulindac |
4.86 | 11245490 12394442 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.53 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.53 | 17551590 15992940 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.81 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
5.81 | 15699352 16775033 15369732 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.03 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
2.94 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.92 | 16316344 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.71 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.03 | 16085563 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.58 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.06 | 19850784 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.07 | 19642359 17506722 17107899 16891316 17217047 19075265 17368321 16788101 17339181 17361223 9834237 17649720 19035177 16823087 17712046 17294898 19225113 12679006 15748426 16935935 16331271 19029980 17301526 16766008 16140955 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.21 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.06 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.75 | 18407596 18522880 19638242 20032147 18665156 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
Sulindac |
4.14 | 12468960 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
4.83 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
4.83 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.83 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
4.83 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
6.40 | 16611625 16610002 19460945 12587719 19784758 11587558 19014921 12969438 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
6.40 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Sulindac |
6.40 | 16867024 14986274 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.12 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Butylated Hydroxytoluene |
10.34 | 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
10.34 | 18648771 18754104 19073162 9163691 19551842 16942905 15885732 20405173 19427195 21047994 15175105 10737359 19996281 19256749 2422723 19833225 19255062 19426721 2862719 20492335 20434301 18644402 18977376 19690152 20118626 12112319 19254457 19812893 19850985 20137499 20501860 12771043 18978307 20452335 20101389 19499222 19090486 19638242 19642983 21278145 21167192 20583210 21071580 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
10.34 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.34 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
9.38 | 18308698 19009564 17854601 18079962 19004024 18544905 18253720 16267830 2563599 18775883 18164116 19539802 17174075 17942915 9362446 19126423 21159647 3124819 18282651 18093689 19519916 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
9.38 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.38 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Butylated Hydroxytoluene |
8.36 | 11246140 15390079 19359593 18597497 19925653 16337739 11696405 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
8.36 | 21163286 20970405 6695378 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
8.36 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Sulindac |
8.36 | 19359593 15713900 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
8.36 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
8.36 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.37 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.68 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.44 | 15621674 |
MESH:D008275 |
Magnesium Deficiency |
|
Magnesium |
6.31 | 17823441 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.63 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Butylated Hydroxytoluene |
9.67 | 1500032 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
9.67 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
9.67 | 11731420 16827153 14580682 19196723 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.42 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.73 | 17453147 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
7.15 | 16827129 |
MESH:D008545 |
Melanoma |
|
Sulindac |
7.15 | 16642371 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
7.15 | 19393235 12393984 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
7.15 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.05 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.44 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.29 | 16940565 |
MESH:D001523 |
Mental Disorders |
|
Phosphates |
4.88 | 12686366 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.01 | 17638057 |
MESH:D008881 |
Migraine Disorders |
|
Aspirin |
8.13 | 15240983 |
MESH:D008881 |
Migraine Disorders |
|
Magnesium |
8.13 | 18803445 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.38 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.66 | 17415656 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.01 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Aspirin |
6.05 | 12692751 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
6.05 | 19429709 15857846 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.91 | 12213967 |
MESH:D009325 |
Nausea |
|
Aspirin |
5.09 | 15240983 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
9.22 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
9.22 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
9.22 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.47 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.35 | 16946489 16594593 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.87 | 19200415 19189210 19196722 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.64 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.89 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.09 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.09 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
2.97 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.20 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
13.49 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
13.49 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Sulindac |
13.49 | 16850258 17266991 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.99 | 20387270 |
MESH:D010003 |
Osteoarthritis |
|
Aspirin |
3.98 | 7009135 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.70 | 17882678 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.01 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.31 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
15.28 | 16870215 |
MESH:D010146 |
Pain |
|
Aspirin |
15.28 | 6995502 6363464 |
MESH:D010146 |
Pain |
|
Sulindac |
15.28 | 3291741 |
MESH:D010146 |
Pain |
|
Tretinoin |
15.28 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
8.45 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Sulindac |
8.45 | 16820089 11504793 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
8.45 | 15976015 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.12 | 12520081 |
MESH:D010438 |
Peptic Ulcer Hemorrhage |
|
Aspirin |
5.41 | 11156591 |
MESH:D020795 |
Photophobia |
|
Aspirin |
5.63 | 15240983 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.03 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.03 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Butylated Hydroxytoluene |
5.03 | 11893704 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.43 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.44 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.06 | 11399792 11118676 11222880 11896295 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.39 | 15749863 15897917 16729912 16868541 18437689 16888761 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.39 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.48 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.66 | 16723453 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.09 | 17922066 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.71 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.98 | 16116481 16283617 |
MESH:D012220 |
Rhinitis |
|
Aspirin |
4.26 | 12372130 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.87 | 17203757 15675481 16767912 15625365 18313854 17710206 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.11 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.66 | 17846226 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Aspirin |
5.13 | 12269725 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
9.11 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.11 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.11 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.44 | 16767912 15625365 17203757 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.16 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.91 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.39 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.39 | 17261132 |
MESH:D020521 |
Stroke |
|
Aspirin |
4.27 | 16403987 |
MESH:D013927 |
Thrombosis |
|
Aspirin |
4.40 | 17672075 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.77 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
16.32 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
16.32 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Propylthiouracil |
16.32 | 15710170 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
16.32 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.67 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.15 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
5.04 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
5.04 | 17572228 16712894 8653321 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
8.49 | 10982225 |
MESH:D014581 |
Urticaria |
|
Aspirin |
8.49 | 10982225 20485159 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.56 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Sulindac |
4.47 | 18645019 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.48 | 16752155 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.47 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.09 | 17678736 17334414 17638931 16364871 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.93 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.12 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.85 | 16287080 |